Foslift Granules 3.2 gm is used to treat high blood calcium levels caused by hyperparathyroidism (overactive parathyroid glands) and multiple myelomatosis (blood cancer). Additionally, Foslift Granules 3.2 gm is also used to treat low blood potassium due to vitamin D resistant rickets (a bone disease that does not respond to vitamin D treatment) and vitamin D resistant hypophosphatemic osteomalacia (bone softening condition). 

Foslift Granules 3.2 gm contains ‘Sodium acid phosphate’, which binds with the calcium; this helps the calcium levels go back to normal. It also helps in increasing the levels of potassium in the blood. Thereby, Foslift Granules 3.2 gm helps in treating high calcium and low potassium levels. You are advised to take Foslift Granules 3.2 gm for as long as your doctor has prescribed it for you, depending on your medical condition. In some cases, you may experience common side effects such as stomach upset, diarrhoea, abdominal pain, nausea, and vomiting. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if you experience these side effects persistently. 

Consult a doctor before taking Foslift Granules 3.2 gm if you are pregnant or breastfeeding. Foslift Granules 3.2 gm should be given to children only if prescribed by a doctor. Inform your doctor if you are on sodium controlled diet or if you have reduced kidney function. Keep your doctor informed about your health condition and the medicines you are taking to rule out any side effects/interactions.

Foslift Granules 3.2 gm is used to treat high blood calcium levels caused by hyperparathyroidism (overactive parathyroid glands) and multiple myelomatosis (blood cancer). Besides this, Foslift Granules 3.2 gm is also used to treat low blood potassium due to vitamin D-resistant rickets (a bone disease that does not respond to vitamin D treatment) and vitamin D-resistant hypophosphatemic osteomalacia (bone softening condition). Foslift Granules 3.2 gm binds with the calcium and makes the calcium levels go back to normal. It also helps in increasing the levels of potassium in the blood. Thereby, Foslift Granules 3.2 gm helps in treating high calcium and low potassium levels.

• Stomach upset
• Abdominal pain
• Nausea
• Vomiting
• Diarrhoea

Do not take Foslift Granules 3.2 gm if you are allergic to any of its components. Talk to your doctor if you have congestive heart failure, high blood pressure, sodium restrictions in your diet, pre-eclamptic toxaemia (high blood pressure during pregnancy), or kidney or liver disease. Consult your doctor before taking Foslift Granules 3.2 gm if you are pregnant or breastfeeding. Foslift Granules 3.2 gm should be given to children only if prescribed by a doctor.

Drug-Drug Interactions: Foslift Granules 3.2 gm may have interaction with antacid medicines.

Drug-Food Interactions: No interaction found/established.

Drug-Disease Interactions: Inform your doctor if you have kidney impairment.

• Maintain a well-balanced diet containing fresh fruits, vegetables, and whole grains.
• Drink plenty of water. Staying hydrated lowers calcium levels and prevents kidney stones.
• Smoking can cause bone loss. Quit smoking.
• Exercise regularly as it helps promote bone health.

Regular monitoring of electrolyte levels while taking Foslift Granules 3.2 gm is advised.

Hyperparathyroidism: The parathyroid glands become overactive and secrete too much parathyroid hormone. This leads to hypercalcemia, i.e., a rise in calcium levels in the blood. Symptoms include muscle pain, joint weakness, tiredness, loss of appetite, bone pain, nausea, vomiting, and constipation.

Multiple myelomatosis: It is a type of cancer in which the plasma cells become cancerous and multiply. Plasma cells are a type of white blood cells in the bone marrow. Multiple myelomatosis damages the bones, kidneys, immune system, and red blood cell count. Hypercalcemia is the most frequent metabolic complication of myeloma.

Vitamin D-resistant hypophosphatemic osteomalacia or rickets: It is a bone disease that does not respond to treatment with vitamin D. This condition is characterised by hypophosphatemia (low phosphorus levels in the blood), diminished intestinal absorption of calcium, and increased renal clearance of phosphate. It is a metabolic disease that leads to reduced mineralisation of the bone matrix.